Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1

Modern Pathology

Volumn 18, Issue 11, 2005, Pages 1471-1481

  Lewis Jr , James S ^a,b   Ritter, Jon H ^a   El Mofty, Samir ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunohistochemistry; MOC 31; p63; Sarcomatoid carcinoma; TTF 1

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN; PROTEIN MOC 31; PROTEIN P63; PROTEIN TTF 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CA-15-3 ANTIGEN; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; SARCOMA; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 27144532355     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800451     Document Type: Article

References (25)

1. Choi HR, Sturgis EM, Rosenthal DI, et al. Sarcomatoid carcinoma of the head and neck; molecular evidence for evolution and progression from conventional squamous cell carcinoma. Am J Surg Pathol 2003;27: 1216-1220.
2. Nappi O, Glasner SD, Swanson PE, et al. Biphasic and monophasic sarcomatoid carcinomas of the lung. A reappraisal of 'carcinosarcomas' and 'spindle cell carcinomas'. Am J Clin Pathol 1994;102: 331-340.
3. Nappi O, Wick MR. Sarcomatoid neoplasms of the respiratory tract. Semin Diagn Pathol 1993;10: 137-147.
4. Torenbeek R, Blomjous CEM, deBruin PC, et al. Sarcomatoid carcinoma of the urinary bladder - clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol 1994;18:241-249.
5. Torenbeek R, Hermsen MAJA, Meijer GA, et al. Analysis by comparative hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects. J Pathol 1999;189:338-343.
6. Ikegami H, Iwasaki H, Ohjimi Y, et al. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients. Hum Pathol 2000;31:332-340.
7. Jones EC, Young RH. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Mod Pathol 1997;10: 908-916.
8. Matsui K, Kitagawa M, Miwa A. Lung carcinoma with spindle cell components; sixteen cases examined by immunohistochemistry. Hum Pathol 1992;23: 1289-1297.
9. Thompson LDR, Weineke JA, Miettinen M, et al. Spindle cell (sarcomatoid) carcinomas of the larynx; a clinicopathologic study of 187 cases. Am J Surg Pathol 2002;26:153-170.
10. Nakamura N, Miyagi E, Murata S, et al. Expression of thyroid transcription factor 1 in normal and neoplastic lung tissue. Mod Pathol 2002;15:1058-1067.
11. Souhami RL, Beverley PC, Bobrow LG, et al. Antigens of lung cancer: results of the second international workshop on lung cancer antigens. J Natl Cancer Inst 1991;83:609-612.
12. Edwards C, Oates J. OV632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material. J Clin Pathol 1995;48: 626-630.
13. DiComo CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
14. Pruneri G, Pignataro L, Manzotti M, et al. p63 in laryngeal squamous cell carcinoma: evidence for a role in TA-p63 down regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 2002;82:1327-1334.
15. Wang BY, Gil J, Kaufman D, et al. p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 2002;33: 921-926.
16. Langner C, Ratschek M, Tsybrovskyy O, et al. p63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003;51:1097-1099.
17. Deyrup AT, Montgomery E, Fisher C. Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg Pathol 2004;28:178-182.
18. Meis JM, Enzinger FM, Martz KL, et al. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.
19. Moran CA, Suster A, Abbondanzo SL, et al. Primary leiomyosarcomas of the lung: a clinicopathologic and immunohistochemical study of 18 cases. Mod Pathol 1997;10:121-128.
20. Rosenberg AE, O'Connell JX, Dickersin GR, et al. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol 1993;24:284-293.
21. Rubin BP, Fletcher CD. Myxoid leiomyosarcoma of soft tissue, an underrecognized variant. Am J Surg Pathol 2000;24:927-936.
22. Krassilnik N, Gologan O, Ghali V, et al. p63 and p16 expression in spindle cell carcinomas of the head and neck. Mod Pathol 2004;17(Suppl 1):226A (Abstract #953).
23. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;20: 859-872.
24. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-1371.
25. Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol 2004;17:765-771.